Showing results (111-120 of 1,315) with videos related to
Sort By:
Pageof 132
Cardiovascular Toxicology|July 27, 2007
Novel antioxidants in anthracycline cardiotoxicityKálmán Hideg, Tamás KálaiCardiovascular Toxicology|January 22, 2004
Effects of angiotensin-converting enzyme inhibitor on delayed-onset doxorubicin-induced cardiotoxicityRobert J Boucek, Ann Steele, Ann Miracle, et al.Cardiovascular Toxicology|October 8, 2004
Direct, DNA pol-gamma-independent effects of nucleoside reverse transcriptase inhibitors on mitochondrial bioenergeticsKaleb C Lund, Kendall B WallaceCardiovascular Toxicology|October 8, 2004
Cardiovascular effects of HAART in infants and children of HIV-infected mothersKarolina M Zareba, Jill E Lavigne, Steven E LipshultzCardiovascular Toxicology|September 17, 2004
Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical studyJill E Lavigne, William T Shearer, Bruce Thompson, et al.Cardiovascular Toxicology|October 28, 2008
A hyperlipidemic rabbit model provides new insights into pulmonary zinc exposure effects on cardiovascular healthAdriana J LaGier, Nick D Manzo, Alex P Carll, et al.Cardiovascular Toxicology|February 16, 2010
In utero exposure of female CD-1 mice to AZT and/or 3TC: II. Persistence of functional alterations in cardiac tissueSalina M Torres, Rao L Divi, Dale M Walker, et al.Cardiovascular Toxicology|February 27, 2010
Exposure to low-dose trichloroethylene alters shear stress gene expression and function in the developing chick heartOm Makwana, Nicholas M P King, Lauren Ahles, et al.Cardiovascular Toxicology|December 31, 2005
Cardiovascular toxicities upon manganese exposureYueming Jiang, Wei ZhengCardiovascular Toxicology|December 31, 2005
Reduction of 13-deoxydoxorubicin and daunorubicinol anthraquinones by human carbonyl reductaseAndrew Slupe, Berea Williams, Corianton Larson, et al.Pageof 132